Insulin glargine 300 U/
            mL
            versus first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 12‐month outcomes of
            ACHIEVE
            Control, a prospective, randomized, pragmatic real‐life clinical trial

Luigi Meneghini; Lawrence Blonde; Jasvinder Gill; Arnaud Dauchy; Andrius Bacevicius; Jodi Strong; Timothy S. Bailey

doi:10.1111/dom.14116

Insulin glargine 300 U/ mL versus first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 12‐month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real‐life clinical trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14116 ◽

2020 ◽

Vol 22 (11) ◽

pp. 1995-2003

Author(s):

Luigi Meneghini ◽

Lawrence Blonde ◽

Jasvinder Gill ◽

Arnaud Dauchy ◽

Andrius Bacevicius ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Basal Insulin ◽

First Generation ◽

Real Life ◽

Insulin Analogues

Download Full-text

A pragmatic randomized clinical trial of insulin glargine 300 U/ mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control study

Diabetes Obesity and Metabolism ◽

10.1111/dom.14152 ◽

2020 ◽

Vol 22 (11) ◽

pp. 2004-2012

Author(s):

Luigi F. Meneghini ◽

Sean D. Sullivan ◽

Gerry Oster ◽

Robert Busch ◽

Anna M. G. Cali ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Randomized Clinical Trial ◽

Basal Insulin ◽

First Generation ◽

Insulin Analogues ◽

Control Study

Download Full-text

128-LB: Insulin Glargine 300 U/mL (Gla-300) vs. First-Generation Basal Insulins (BI) in Insulin-Naïve Type 2 Diabetes (T2D) Patients (Pts) With and Without Cardiovascular Disease (CVD): Outcomes of the Randomized Pragmatic Real-Life Clinical Trial ACHIEVE Control

Diabetes ◽

10.2337/db19-128-lb ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 128-LB ◽

Cited By ~ 1

Author(s):

JUAN P. FRIAS ◽

PIERRE EVENOU ◽

DAVID DALTON ◽

KATHLEEN M. DUNGAN

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Clinical Trial ◽

Insulin Glargine ◽

First Generation ◽

Real Life

Download Full-text

1038-P: Insulin Glargine 300 U/ml (Gla-300) vs. First-Generation Standard-of-Care Basal Insulin Analogs (SOC-BI) in Insulin-Naïve Patients with Type 2 Diabetes (T2D): Impact of Renal Function on the Outcomes of the Randomized Pragmatic Real-Life Achieve Control S

Diabetes ◽

10.2337/db20-1038-p ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 1038-P

Author(s):

LUIGI MENEGHINI ◽

ALICE CHENG ◽

PIERRE EVENOU ◽

JASVINDER GILL ◽

AYAD MOHAMED ◽

...

Keyword(s):

Type 2 Diabetes ◽

Renal Function ◽

Insulin Glargine ◽

Basal Insulin ◽

First Generation ◽

Real Life ◽

Standard Of Care ◽

Insulin Analogs

Download Full-text

Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5

Diabetes Care ◽

10.2337/dc15-1531 ◽

2015 ◽

Vol 39 (1) ◽

pp. 92-100 ◽

Cited By ~ 52

Author(s):

John B. Buse ◽

Helena W. Rodbard ◽

Carlos Trescoli Serrano ◽

Junxiang Luo ◽

Tibor Ivanyi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Randomized Clinical Trial ◽

Basal Insulin ◽

Previously Treated

Download Full-text

Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2015.09.015 ◽

2015 ◽

Vol 110 (2) ◽

pp. 158-165 ◽

Cited By ~ 10

Author(s):

María S. Ruiz de Adana ◽

Natalia Colomo ◽

Cristina Maldonado-Araque ◽

María I. Fontalba ◽

Francisca Linares ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Randomized Clinical Trial ◽

Respiratory Disease ◽

Basal Insulin ◽

Glucose Monitoring ◽

Efficacy And Safety ◽

Nph Insulin

Download Full-text

103-LB: Real-World Persistence, Adherence, Health Care Resource Utilization, and Costs in People with Type 2 Diabetes (T2D) Switching from Basal Insulin (BI) to Second-Generation BI (Insulin Glargine 300 U/mL [Gla-300]) vs. First-Generation BI (Insulin Glargine 1

Diabetes ◽

10.2337/db21-103-lb ◽

2021 ◽

Vol 70 (Supplement 1) ◽

pp. 103-LB

Author(s):

EUGENE WRIGHT ◽

JASVINDER GILL ◽

SAMUEL HUSE ◽

XUAN LI ◽

TIMOTHY REID ◽

...

Keyword(s):

Type 2 Diabetes ◽

Health Care ◽

Insulin Glargine ◽

Resource Utilization ◽

Real World ◽

Basal Insulin ◽

First Generation ◽

Health Care Resource ◽

Health Care Resource Utilization

Download Full-text

Randomized double‐blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4

Diabetes Obesity and Metabolism ◽

10.1111/dom.12696 ◽

2016 ◽

Vol 18 (11) ◽

pp. 1072-1080 ◽

Cited By ~ 17

Author(s):

T. Blevins ◽

T. R. Pieber ◽

G. Colón Vega ◽

S. Zhang ◽

E. J. Bastyr ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Insulin Lispro ◽

Basal Insulin ◽

Double Blind ◽

Prandial Insulin ◽

Double Blind Clinical Trial

Download Full-text

Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2006.00685.x ◽

2007 ◽

Vol 9 (3) ◽

pp. 290-299 ◽

Cited By ~ 179

Author(s):

O. Klein ◽

J. Lynge ◽

L. Endahl ◽

B. Damholt ◽

L. Nosek ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Basal Insulin ◽

Insulin Detemir ◽

Insulin Analogues ◽

Comparable Time

Download Full-text

Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients

BMC Endocrine Disorders ◽

10.1186/1472-6823-12-21 ◽

2012 ◽

Vol 12 (1) ◽

Cited By ~ 5

Author(s):

Marie Jakobsen ◽

Mette Dalsgaard ◽

Morten Hørmann ◽

Daniél Vega Møller

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Detemir ◽

Real Life ◽

Insulin Analogues ◽

Diabetes Patients

Download Full-text

Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study

Diabetes Obesity and Metabolism ◽

10.1111/dom.13345 ◽

2018 ◽

Vol 20 (9) ◽

pp. 2148-2158 ◽

Cited By ~ 33

Author(s):

Sean D. Sullivan ◽

Timothy S. Bailey ◽

Ronan Roussel ◽

Fang Liz Zhou ◽

Zsolt Bosnyak ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Comparative Effectiveness ◽

Basal Insulin ◽

Insulin Analogues ◽

Insulin Degludec

Download Full-text